In hepatoma cells, DDX3 maintains the transcription of a subset of tumor-suppressive miRNA, including miR-122, by inhibiting the recruitment of DNMT3A to the target promoters leading to reduced hypermethylation on these miRNA promoters25. This evidence concerns the gene DNMT3A and hepatocellular carcinoma.